Are you Dr. Medzihradsky?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2170 South Ave
South Lake Tahoe, CA 96150Phone+1 530-542-3000Fax+1 530-541-8723
Summary
- Dr. Oliver Medzihradsky, MD is an internist in South Lake Tahoe, California. He is currently licensed to practice medicine in California, Nevada, and North Carolina. He is affiliated with Kaiser Permanente San Francisco Medical Center and is an Assistant Professor at University of California.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Pediatric Infectious Diseases, 2008 - 2011
- University of North Carolina HospitalsResidency, Internal Medicine/Pediatrics, 1999 - 2005
- University of Rochester School of Medicine and DentistryClass of 1999
Certifications & Licensure
- CA State Medical License 2006 - 2025
- NV State Medical License 2005 - 2025
- NC State Medical License 2002 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults Start of enrollment: 2020 Jan 14
Publications & Presentations
PubMed
- 38 citationsEffectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia...Michelle S. Hsiang, Henry Ntuku, Kathryn W. Roberts, Mi-Suk Kang Dufour, Brooke Whittemore
Lancet. 2020-04-25 - 12 citationsApplying clinical guidelines to pediatric practice.Michael D. Cabana, Oliver F Medzihradsky, Haya R Rubin, Gary L. Freed
Pediatric Annals. 2001-05-01 - 13 citationsStudy protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and ve...Oliver F. Medzihradsky, Immo Kleinschmidt, Davis R. Mumbengegwi, Kathryn W. Roberts, Patrick McCreesh
BMJ Open. 2018-01-01
Press Mentions
- Vaccine Maker Eyes the Nose for First Covid Clinical TrialMarch 16th, 2021